MediWound Initiates the VALUE Global Phase III Pivotal Trial of EscharEx® for Treatment of Venous Leg Ulcers
Provided By GlobeNewswire
Last update: Feb 12, 2025
Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closure
Interim analysis planned after 65% of patients complete treatment, expected in mid-2026
Read more at globenewswire.com
